We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About OmniBRx Biotechnologies Stock

Invest in or calculate the value of your shares in OmniBRx Biotechnologies or other pre-IPO companies through EquityZen's platform.

Get Started

OmniBRx Biotechnologies Stock (OMRB)

OmniBRx Biotechnologies produces technologically-advanced bioreactors for the pharmaceutical industry.

About OmniBRx Biotechnologies Stock

Founded

2016

Industries

Software, Artificial Intelligence, Data and Analytics

The Omnibrx Biotechnologies brought is an universal solution for the most efficient adherent cell culture processing with ultimate simplicity and scalability. The compact system, designed for quick implementation and ease-of-use, represents a new generation of rigid wall single-use bioreactors. Central to the CellBRx bioreactors technology is the use of a compact rotating dynamic-bed design, filled with custom disc shaped macro-carriers. This matrix discs are made of medical grade non-woven polyester microfibers (USP Class VI, ISO 10993 certifications) and available from 0.25L to 1000L working volume size.

OmniBRx Biotechnologies Management

Leadership team at OmniBRx Biotechnologies

CEO & Founder

Ravindra Patel

Locked Features

Join now and verify your accreditation status to gain access to:

  • OmniBRx Biotechnologies current valuation
  • OmniBRx Biotechnologies stock price
  • Available deals in OmniBRx Biotechnologies and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in OmniBRx Biotechnologies stock?

Accredited investors can buy pre-IPO stock in companies like OmniBRx Biotechnologies through EquityZen funds. These investments are made available by existing OmniBRx Biotechnologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell OmniBRx Biotechnologies stock?

Shareholders can sell their OmniBRx Biotechnologies stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."